← FDA DRUG APPROVALS

FDA ANDA · ANDA202592

DESLORATADINE

Sponsor: TARO

APPLICATION
ANDA202592
TYPE
ANDA
ORIGINAL APPROVAL
2015-06-30
LATEST ACTION
2015-06-30
ROUTE
ORAL
DOSAGE FORM
SOLUTION
MARKETING STATUS
Discontinued

Products

DESLORATADINEDiscontinued
DESLORATADINE 0.5MG/ML · SOLUTION · ORAL

Approval history

2015-06-30UNKNOWN · OriginalAP
VIEW ON DRUGS@FDA ↗

Related on SPEQ

Pharma industryGMP disciplineFDA drug shortagesFDA enforcement & recalls

Source: FDA Drugs@FDA. SPEQ is not affiliated with the FDA; this is a reference view of public FDA data, not medical, legal, or regulatory advice.

Weekly Briefing

Get the Weekly GxP Briefing

Curated regulatory intelligence — enforcement, recalls, guidance, and quality signals — in one practitioner-grade email each week. Free.

Read a past issue →